Reviva Pharmaceuticals Holdings, Inc

10080 N Wolfe Rd Ste SW3200
Cupertino, CA 95014

Reviva Pharmaceuticals Holdings, Inc. is a clinical-stage pharmaceutical company based in Cupertino, California, focused on discovering and developing novel therapies for central nervous system, respiratory, and metabolic diseases. The company aims to address significant unmet medical needs and improve patient outcomes through the development of safer and more effective treatment options.

Reviva's lead drug candidate, brilaroxazine (RP5063), is currently in clinical development for various neuropsychiatric indications, including schizophrenia, bipolar disorder, and attention deficit hyperactivity disorder (ADHD). The company leverages chemical genomics-driven technology to create innovative therapeutics that can make a meaningful impact on patients' lives.

Generated from the website

Own this business?
See a problem?

You might also like

United StatesCaliforniaCupertinoReviva Pharmaceuticals Holdings, Inc

Partial Data by Infogroup (c) 2025. All rights reserved.